These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 7945512

  • 1. Calcium antagonistic vasodilator mechanisms of brovincamine fumarate studied in canine cerebral artery.
    Tanaka Y, Morimoto K, Ishii K, Nakayama K.
    Arzneimittelforschung; 1994 Jul; 44(7):803-8. PubMed ID: 7945512
    [Abstract] [Full Text] [Related]

  • 2. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H, Hashizume M, Masuda Y, Fujitani B, Hosoki K.
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [Abstract] [Full Text] [Related]

  • 3. Effects of endothelin-1 on the myogenic contraction of canine cerebral artery in response to quick stretch.
    Tanaka Y, Shigenobu K, Nakayama K.
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):95-101. PubMed ID: 11458989
    [Abstract] [Full Text] [Related]

  • 4. Measurement of intracellular Ca2+ concentration changes by use of fura-2 in the generation of myogenic contraction of dog cerebral artery in response to quick stretch.
    Tanaka Y, Nakayama K.
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):169-86. PubMed ID: 9583091
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of diltiazem and nitroglycerin on cytosolic Ca2+ concentration and on force in the bovine ophthalmic artery.
    Hiroishi G, Kobayashi S, Nishimura J, Inomata H, Kanaide H.
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2612-23. PubMed ID: 8977475
    [Abstract] [Full Text] [Related]

  • 6. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
    Kikkawa K, Murata S, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
    [Abstract] [Full Text] [Related]

  • 7. Methanol-induced contraction of canine cerebral artery and its possible mechanism of action.
    Li W, Altura BT, Altura BM.
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):361-8. PubMed ID: 9653067
    [Abstract] [Full Text] [Related]

  • 8. Evidence for the possible involvement of Ca2+ entry blockade in the relaxation by class I antiarrhythmic drugs in the isolated pig coronary smooth muscle.
    Tanaka Y, Kamibayashi M, Yamashita Y, Imai T, Tanaka H, Nakahara T, Ishii K, Shigenobu K.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):56-66. PubMed ID: 11862334
    [Abstract] [Full Text] [Related]

  • 9. Changes in cytosolic Ca2+ measured by use of fura-2 and contraction produced by quick stretch and various stimulants in canine cerebral artery.
    Tanaka Y, Nakayama K, Shigenobu K.
    Res Commun Mol Pathol Pharmacol; 1998 Oct; 102(1):79-92. PubMed ID: 9920348
    [Abstract] [Full Text] [Related]

  • 10. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
    Nakayama K, Kurihara J, Miyajima Y, Ishii K, Kato H.
    Arzneimittelforschung; 1985 Oct; 35(4):687-93. PubMed ID: 4015735
    [Abstract] [Full Text] [Related]

  • 11. Possible mechanism of the potent vasoconstrictor responses to ryanodine in dog cerebral arteries.
    Asano M, Kuwako M, Nomura Y, Suzuki Y, Shibuya M, Sugita K, Ito K.
    Eur J Pharmacol; 1996 Sep 05; 311(1):53-60. PubMed ID: 8884236
    [Abstract] [Full Text] [Related]

  • 12. Actions of 4-chloro-3-ethyl phenol on internal Ca2+ stores in vascular smooth muscle and endothelial cells.
    Low AM, Sormaz L, Kwan CY, Daniel EE.
    Br J Pharmacol; 1997 Oct 05; 122(3):504-10. PubMed ID: 9351507
    [Abstract] [Full Text] [Related]

  • 13. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE.
    Dan Med Bull; 1996 Dec 05; 43(5):429-47. PubMed ID: 8960816
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of TA-3090 (8-chloro diltiazem) related to its cerebrovascular protective properties.
    Bevan JA, Kaminow L, Laher I, Thompson LP.
    Circulation; 1989 Dec 05; 80(6 Suppl):IV178-83. PubMed ID: 2598453
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vasodilator mechanism of KB-944, a new calcium antagonist.
    Morita T, Kanazawa T, Ito K, Nose T.
    Arzneimittelforschung; 1982 Dec 05; 32(9):1043-6. PubMed ID: 6890823
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B, Milon D, Bentue-Ferrer D, Allain H, Rault B, Van den Driessche J.
    Res Commun Chem Pathol Pharmacol; 1994 Mar 05; 83(3):255-69. PubMed ID: 8008975
    [Abstract] [Full Text] [Related]

  • 19. Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release.
    Cao YX, Zhang W, He JY, He LC, Xu CB.
    Vascul Pharmacol; 2006 Sep 05; 45(3):171-6. PubMed ID: 16807126
    [Abstract] [Full Text] [Related]

  • 20. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries.
    Müller-Schweinitzer E, Neumann P.
    J Cereb Blood Flow Metab; 1983 Sep 05; 3(3):354-61. PubMed ID: 6223932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.